Ergomed announce £25mln acquisition - Miroslav Reljanović, CEO, Ergomed 00:00:00

Share On Facebook Share On Twitter

Ergomed PLC (AIM:ERGO, ETR:2EM) Miroslav Reljanović, Egomed’s executive chairman talks about the acquisition of pharmaceutical quality assurance specialist ADAMAS for £25.6mln cash.

Recent Videos